IL22 and colitis: In an experiment with Il‐23‐/WTRag−/− mice, neutralization of endogenous IL‐22 with anti‐IL‐22 antibody after anti‐CD40 injections leads to a significant reduction in weight loss, colitis scores, and colon pathology.34